Albuterol CFC Phase-Out Date Needed Now For HFA Ramp Up, Firms Says
Executive Summary
A lack of a definitive date for the phase-out of chlorofluorocarbon propelled albuterol metered dose inhalers could delay ramp up of production of inhalers that use non ozone depleting substances, manufacturers suggested at the June 10 meeting of FDA's Pulmonary-Allergy Drugs Advisory CommitteeYou may also be interested in...
CFC Albuterol To Be Pulled In 2008; FDA Says HFA Makers Need Ramp-Up Time
FDA is basing its Dec. 31, 2008 deadline for the withdrawal of CFC-containing albuterol on the concern that manufacturers will need additional time to ramp-up production of hydrofluoroalkane products
CFC Albuterol To Be Pulled In 2008; FDA Says HFA Makers Need Ramp-Up Time
FDA is basing its Dec. 31, 2008 deadline for the withdrawal of CFC-containing albuterol on the concern that manufacturers will need additional time to ramp-up production of hydrofluoroalkane products
GSK Offers Price Freeze On Ventolin HFA In Bid For Early Phase-Out Of CFCs
GlaxoSmithKline has offered to freeze the wholesale price of its Ventolin HFA inhaler as part of its case for FDA to phase out chlorofluorocarbon albuterol metered-dose inhalers by December 31, 2005
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: